✦ LIBER ✦

Interferon therapy for non-A, non-B chronic hepatitis

✍ Scribed by Lino, Shiro ;Hino, Kunihiko ;Kondo, Toshiro ;Koike, Kazuhiko ;Yasuda, Kiyomi ;Yotsuyanagi, Hiroshi ;Kurokawa, Kiyoshi

Publisher: Springer-Verlag
Year: 1991
Tongue: English
Weight: 533 KB
Volume: 26
Category: Article
ISSN: 0435-1339
DOI: 10.1007/bf02779306

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic non-A, non-B hepati

Treatment of chronic non-A, non-B hepatitis with interferon

✍ Karino, Yoshiyasu ;Matsushima, Takashi ;Saga, Akiyoshi ;Tsuyuguchi, Masako ;Miya 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 407 KB

Hepatitis C viraemia rebound after “succ

Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non-A, non-B hepatitis

✍ Dr. J. A. Garson; S. Brillanti; C. Ring; P. Perini; M. Miglioli; L. Barbara 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 1 views

## Abstract A quantitative polymerase chain reaction (PCR) assay for hepatitis C viral RNA (HCV‐RNA) was used to monitor viraemia levels in six patients at multiple time points before, during, and after interferon therapy for chronic non‐A, non‐B hepatitis (NANBH). Prior to therapy, serum HCV‐RNA w

Interferon and chronic non-A, non-B hepa

Interferon and chronic non-A, non-B hepatitis: Whom are we treating?

✍ Harold O. Conn; Ronald L. Koretz 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

Chronic hepatitis C (non-A, non-B hepatitis) is a common and often progressive viral liver diseeee. To aegees the efficacy of therapy with the antiviral agent interferon alfa, we randomly assigned 166 patients with chronic hepatitis C to treatment with either 3 million or 1 million units of recombin

Interferon-α2b therapy reduces liver fib

Interferon-α2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation

✍ Noboru Manabe; Michèle Chevallier; Philippe Chossegros; Xavier Causse; Sylviane 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Activity of antibodies to hepatitis C vi

Activity of antibodies to hepatitis C virus of patients with chronic non-A, non-B hepatitis decreases during interferon α therapy

✍ Yoshioka, Kentaro ;Kakumu, Shinichi ;Hayashi, Hisao ;Shinagawa, Tadashi ;Wakita, 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 202 KB

Autoantibodies during α-interferon thera

Autoantibodies during α-interferon therapy for chronic hepatitis B

✍ G. Fattovich; C. Betterle; L. Brollo; B. Pedini; G. Giustina; G. Realdi; A. Albe 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. Thirteen different antibodies from the sera of 32 patients with chronic hepatitis B treated with alpha-interferon (alpha-IFN) were tested. Seventeen HBeAg-positive patients receive